Combination pill for cardiovascular disease--reply

Affiliations

¹ International Centre for Circulatory Health, Imperial College London, London, England.
² George Institute for Global Health, Sydney, Australia.

Comment

Simon Thom et al. JAMA. 2014.

. 2014 Jan 1;311(1):93-4.

doi: 10.1001/jama.2013.283146.

¹ International Centre for Circulatory Health, Imperial College London, London, England.
² George Institute for Global Health, Sydney, Australia.

No abstract available

Comment on

Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A; UMPIRE Collaborative Group. Thom S, et al. JAMA. 2013 Sep 4;310(9):918-29. doi: 10.1001/jama.2013.277064. JAMA. 2013. PMID: 24002278 Clinical Trial.
Combination pill for cardiovascular disease.
Tsujimoto T, Yamamoto-Honda R. Tsujimoto T, et al. JAMA. 2014 Jan 1;311(1):92-3. doi: 10.1001/jama.2013.283130. JAMA. 2014. PMID: 24381970 No abstract available.
Combination pill for cardiovascular disease.
Carey M. Carey M. JAMA. 2014 Jan 1;311(1):93. doi: 10.1001/jama.2013.283133. JAMA. 2014. PMID: 24381971 No abstract available.